Attention-Deficit Hyperactivity Disorder (ADHD) Market : Facts, Figures and Analytical Insights 2020-2026

The Attention-Deficit Hyperactivity Disorder (ADHD) Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Buy The Report (USD $900 only):
https://www.marketinsightsreports.com/report/purchase/04282009440?mode=su?source=openpr&Mode=12

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Johnson & Johnson, Pfizer Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited (Shire Plc) and others.

Industry News:

Tuesday, November 27, 2012 – Pfizer Acquires NextWave Pharmaceuticals, Inc.

NEW YORK- Pfizer Inc. (NYSE: PFE) today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD).

Upon the closing of the transaction, Pfizer now holds exclusive North American commercialization rights to Quillivant XR™ (methylphenidate hydrochloride) for extended-release oral suspension, CII, the first once-daily liquid medication approved in the U.S. for the treatment of ADHD. Quillivant XR received approval from the U.S. Food and Drug Administration on September 27, 2012, and is expected to be available in pharmacies in the U.S. in January 2013.

NEW YORK, June 25, 2020 -- The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases and it operates in one of the most diverse and complex markets. The pharmaceutical market is also expected to grow in the coming years, despite the recent growth slowdown felt around the globe. Geographically, North America is expected to retain its leading position in the global pharmaceuticals market with a market share of 45.33% in 2023, improving on its market share compared to 2017. The reasons for the growth projections are the aging and rising population, increasing income levels and emerging medical conditions, including new diseases. Of course, innovations in advanced technology and biologics, nucleic acid therapeutics, cell therapies and bioelectronics & implantables has already attracted investments to the pharmaceutical market. And, in recent years, new segments have appeared that previously were considered taboo, like cannabis and psychedelics. Now, according to NAVADHI Market Research, the global pharmaceutical industry will be worth USD 1.57 Trillion by 2023. Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO), Takeda Pharmaceutical Company Limited (NYSE: TAK), Teva Pharmaceutical Industries Limited (NYSE: TEVA), Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

Market Overview:

ADHD is a complex neurological disorder which creates difficulty for a person in paying attention and in controlling their behavior. The symptoms of ADHD might vary from person to person, but the most common symptoms include restlessness, difficulty in paying attention, hyperactivity, frequent mood swings and difficulty in coping with stress. A person diagnosed with ADHD can suffer from the hyperactive-type, inattentive type or the combined type attention deficit disorder.

The most common factors which cause the attention-deficit hyperactivity disorder in people include exposure to environmental toxins such as high levels of lead at a young age, low birth weight, genes, brain injuries, etc. ADHD can be treated with the use of medication, therapy, education and training or a combination of these treatments.

ADHD has been segmented on the basis of medication type, therapy, age group and distribution channel. The two major kinds of medication for the treatment of ADHD are stimulants and non-stimulants. Various kinds of therapies for ADHD include behavior therapy, cognitive behavioral therapy, interpersonal therapy and family therapy. On the basis of age group, ADHD has been segmented into pediatric, adolescent and adult and the major distribution channels for ADHD are retail pharmacy and hospital pharmacy.

The global attention-deficit hyperactivity disorder (ADHD) market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2019-2023). The market is expected to be driven by various growth enhancing factors such as rising healthcare expenditure, excessive use of smartphones, increasing investments in mental health technology, growing impact of social media, etc. Some of the major challenges faced by the market are misuse of drugs used in the treatment of ADHD and high cost of ADHD treatment.

Click the link to get a Sample Copy of the Report:
https://www.marketinsightsreports.com/reports/04282009440/global-attention-deficit-hyperactivity-disorder-adhd-market-size-trends-and-forecast-2019-2023/inquiry?source=openpr&Mode=12

Regional Analysis For Attention-Deficit Hyperactivity Disorder (ADHD) Market:

For comprehensive understanding of market dynamics, the global Attention-Deficit Hyperactivity Disorder (ADHD) market is analyzed across key geographies namely:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Attention-Deficit Hyperactivity Disorder (ADHD) Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2020–2026.

Following are major Table of Content of Attention-Deficit Hyperactivity Disorder (ADHD) Market:

- Global Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
- Global Market competition by top Players
- Analysis by Regions
- Consumption by Regions
- Consumption, By Types, Revenue and Market share by Types
- Consumption, By Applications, Market share (%) and Growth Rate by Applications
- Complete profiling and analysis of Players
- Industrial Chain, Sourcing Strategy and Downstream Buyers
- Marketing Strategy Analysis, Distributors/Traders
- Global Market Effect Factors Analysis
- Global Market Forecast
- Global Market Research Findings and Conclusion, Appendix, methodology and data source

Finally, all aspects of the Global Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects. The report supplies the international economic competition with the assistance of Porter’s Five Forces Analysis and SWOT Analysis.

For More Information On This Report, Please Visit: https://www.marketinsightsreports.com/reports/04282009440/global-attention-deficit-hyperactivity-disorder-adhd-market-size-trends-and-forecast-2019-2023?source=openpr&Mode=12

We Offer Customization On Report Based On Specific Client Requirement:

– Free country Level analysis for any 5 countries of your choice.
– Free Competitive analysis of any 5 key market players.
– Free 40 analyst hours to cover any other data point.

How we have factored the effect of Covid-19 in our report:

All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

CONTACT US:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.